Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer-Reference-Cited by-同舟云学术

Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer

Published:2012-08-01 Issue:3 Volume:119 Page:575-585
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Dhar Dipok Kumar,Olde Damink Steven W.M.,Brindley James Hal,Godfrey Andrew,Chapman Michael H.,Sandanayake Neomal S.,Andreola Fausto,Mazurek Sybille,Hasan Tayyaba,Malago Massimo,Pereira Stephen P.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.27611/fullpdf

Reference27 articles.

1. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001;West;Br J Cancer.,2006

2. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis;Charatcharoenwitthaya;Hepatology.,2008

3. Serum and bile markers for cholangiocarcinoma;Nehls;Semin Liver Dis.,2004

4. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells;Mazurek;Int J Biochem Cell Biol.,2011

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advancement in Diagnosis of Biliary Tract Cancer through Pathological and Molecular Classifications;Cancers;2024-05-01

2. Rare diseases and pyruvate kinase M2: a promising therapeutic connection;Drug Discovery Today;2024-05

3. Bile liquid biopsy in biliary tract cancer;Clinica Chimica Acta;2023-11

4. Effectiveness for Diagnosis of Malignancy of Bile Pyruvate Kinase M2 in Patients with Indeterminate Biliary Stricture;Surgical Laparoscopy, Endoscopy & Percutaneous Techniques;2023-03-06

5. Metabolic reprogramming and its clinical implication for liver cancer;Hepatology;2023-01-03